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Condensed phase protein sequencing typically relies on N-terminal labeling with phenyliso-
thiocyanate (“Edman” reagent), followed by cleavage of the N-terminal amino acid. Similar
Edman degradation has been observed in the gas phase by collision-activated dissociation of
the N-terminal phenyl thiocarbamoyl protonated peptide [1] to yield complementary b1 and
yn-1 fragments, identifying the N-terminal amino acid. By use of infrared multiphoton (rather
than collisional) activation, and Fourier transform ion cyclotron resonance (rather than
quadrupole) mass analysis, we extend the method to direct analysis of a mixture of tryptic
peptides. We validate the approach with bradykinin as a test peptide, and go on to analyze a
mixture of 25 peptides produced by tryptic digestion of apomyoglobin. A b1
1 ion is observed
for three of the Edman-derivatized peptides, thereby identifying their N-terminal amino-acids.
Search of the SWISS-PROT database gave a single hit (myoglobin, from the correct biological
species), based on accurate-mass FT-ICR MS for as few as one Edman-derivatized tryptic
peptide. The method is robust—it succeeds even with partial tryptic digestion, partial Edman
derivatization, and partial MS/MS IRMPD cleavage. Improved efficiency and automation
should be straightforward. (J Am Soc Mass Spectrom 2001, 12, 288–295) © 2001 American
Society for Mass Spectrometry
A major component of modern proteomics isprotein identification [2]. One of the most gen-eral and most sensitive means of protein iden-
tification is to separate a protein mixture with a two-
dimensional (isoelectric focusing in one direction and
size-exclusion in the other) polyacrylamide gel electro-
phoresis, followed by digestion with trypsin, mass
analysis (to resolve and isolate a particular peptide),
and finally tandem mass spectrometry (MS/MS) to
yield at least a partial primary amino acid sequence
(sequence “tag”) for that peptide [3–7]. A protein data-
base is then searched to find the “tag” sequence in
concert with the peptide nominal mass (to within 50
ppm) and the knowledge that the C-terminal amino
acid is arginine or lysine (based on the known proteo-
lytic specificity of trypsin) [8]. In fact, such a procedure
can yield more information than is necessary for protein
identification. One is therefore led to seek an alternative
procedure that reduces the complexity of the data and
its processing, while retaining enough information for
unique identification of a protein.
Consider first the prospects for identification of a
protein, based only on accurate mass measurements for
some of its component peptides. Improvement in mass
measurement accuracy to ;1 ppm can significantly
limit the number of possible amino acid compositions
based on peptide mass alone [9]. Nevertheless, unique
identification of the amino acid composition of a 1000
Da peptide is not feasible if all possible amino acid
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compositions are considered, because multiple peptides
can have the same elemental composition (chemical
formula) [10]. Interestingly, as the number of amino
acid residues per peptide increases, so does the relative
(not just absolute) number of isomeric doublets (which
are not mass-resolvable except at 10212 mass precision,
based on the rest mass difference corresponding to their
different heat of formation energy). It is easy to see why.
Note that 18 of the 20 (i.e., 90%) of the most common
naturally occurring amino acids may be distinguished
by mass alone (i.e., all but isoleucine vs. leucine). If one
considers only leucine and isoleucine, then of the 400
possible dipeptides, 76 dipeptides have at least one
isomer that is not simply a permutation of the sequence:
18 IX, 18 LX, 18 XI and 18 XL peptides in which X is any
of the other 18 amino acids, plus II, LL, IL, and LI.
However, another 68 dipeptides are each isomeric with
another dipeptide of different amino acid composition.
For example, Ser-Ala and Thr-Gly have exactly the
same elemental composition, namely, C6H12N2O2. It
turns out that only 64% of the 400 possible unmodified
dipeptides (and 39% of the 8,000 possible unmodified
tripeptides) can be distinguished by mass alone. The
percentage drops even lower for longer peptides
and/or if post-translational modifications are consid-
ered (e.g., methionine 1 tyrosine is isomeric with oxi-
dized methionine 1 phenylalanine). And, of course,
even if amino acid composition is uniquely known,
sequence isomers (AB vs. BA) cannot be distinguished
by mass alone.
Fortunately, proteomics typically entails the much
less restrictive requirement of choosing the correct
peptide sequence from a (much smaller) number of
known proteins (e.g., ;85,000 proteins from the SWISS-
PROT database [11]. Specifically, the yeast (Saccharomy-
ces cerevisiae) genome codes for rather more than 6100
proteins [12]. The number of open reading frames in the
human genome is variously estimated at between
35,000 and 150,000 [13]. Because of the limitations of
searches based only on peptide mass, various supple-
mentary MS/MS experiments have been coupled to
mass measurement to identify particular amino acid(s)
in a given peptide. For example, early MS/MS results
on small peptides and proteins revealed sequence-
dependent fragmentation. Thus partial sequences of
peptides have been inferred from collision-induced
dissociation of peptides in (e.g.) triple quadrupole [14]
and ion trap [15, 16] mass analyzers. Matrix-assisted
laser desorption/ionization (MALDI) reflectron time-
of-flight (TOF) MS can yield sequence information by
detection of post-source decay [17, 18], provided that
the peptide has previously been purified or mass-
selected in a prior mass analyzer. The extent and
direction of the fragmentation may be influenced by use
of cationizing agents [19–22], and charge localizing
agents [23–25]. Alternatively, more specific fragmenta-
tions may be achieved through appropriate derivatiza-
tion of the peptide prior to ionization. For example,
sulfonic acid derivatization [26] can increase the yield of
y-type ions [27] for efficient partial sequencing of singly
or doubly charged peptides.
The Edman degradation process has long served as a
standard method to obtain partial N-terminal sequenc-
ing of proteins or peptides in solution [28, 29]. As soon
as mass spectrometry became able to measure the
masses of proteins and peptides, it was applied to
determine peptide sequences [30]. Combined with a
ladder sequencing approach, the spacing between the
peaks leads easily to identification of up to 60 amino-
acids on the N-terminal end of proteins [31]. A similar
approach based on carboxypeptidase allows for identi-
fication of C-terminal amino-acids [32]. Recently, S.
Gaskell et al. showed that the equivalent of a single
Edman degradation stage can be realized for ions in the
gas phase [1]. The peptide of interest is coupled in
solution with phenylisothiocyanate and ionized in an
electrospray source. Following collisional activation,
the PTC-derivatized peptide dissociates specifically to
form a b1 fragment (Scheme 1). The mechanism of that
fragmentation was proposed to be a gas phase analog of
the solution phase Edman degradation. For analytical
purposes, such fragmentation could serve to identify
the N-terminal amino-acid of a peptide. The method
has also been shown to be applicable to the character-
ization of proteins by means of tandem MS of the
unfractionated digest [33, 34].
Here, we further develop the gas-phase Edman degra-
dation technique for application to a mixture of peptides
resulting from proteolytic digestion of a protein with
trypsin. Use of Fourier transform ion cyclotron resonance
(FT-ICR) mass analysis achieves superior mass accuracy
to enhance the specificity of database searching. Use of
infrared multiphoton dissociation (IRMPD) allows for
easily adjustable ion activation without the need for colli-
sion buffer gas (that must otherwise be pumped away
afterward to achieve high mass resolution). We test the
method on bradykinin, and then proceed to demonstrate
its applicability to identification of apomyoglobin from the
full SWISS-PROT database.
Scheme 1
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Experimental
Sample Preparation
Solvents, buffers, bradykinin, and apomyoglobin were
purchased from Sigma (St. Louis, MO). Trypsin and
trypsin immobilized on agarose beads were purchased
from Pierce (Rockford, IL).
Tryptic digestion of apomyoglobin was performed
by standard procedures: 1 mg of apomyoglobin is
dissolved in 0.5 mL of ammonium acetate buffer (0.1 M,
pH 8.1). Immobilized trypsin is added to the solution
and digestion proceeds at 37 °C for 24 h. After removal
of the trypsin beads by centrifugation, the digested
protein is purified on a C8 Sep-Pak cartridge (Waters,
Milford). An aliquot is then diluted to about 10 mM in a
standard methanol/water (50:50) with 2% acetic acid
electrospray solution. Under these conditions, as dis-
cussed below, trypsin digestion is nearly complete, but
some potential cleavage sites are not observed.
For Edman derivatization [1, 35], 200 mg of pure
bradykinin or of the apomyoglobin peptide digest is
dissolved under nitrogen flow in 300 mL of a 1:1:1
ethanol/water/pyridine solution, containing 5% v/v of
phenylisothiocyanate (PITC) reagent. Reaction pro-
ceeds at 45 °C for 30 min. The solvent is then thor-
oughly evaporated under nitrogen flow. The remaining
solid is then dissolved in either acetonitrile or methanol.
Although dissolution is incomplete in either case, either
solution can be analyzed by dilution to ;10 mM in
various electrospray solutions: methanol/water (50:50
and 75:25) and acetonitrile/water (50:50 and 75:25) with
either acetic acid (2–5%) or formic acid (2%) as the
protonating agent. As discussed below, PTC-derivatiza-
tion appears to be nearly complete. Double derivatiza-
tion, when possible, is ;50% efficient.
FT-ICR Mass Analysis
FT-ICR mass spectrometry was performed with a pas-
sively shielded 9.4 T instrument configured for external
accumulation of ions [36] and controlled by a modular
ICR data acquisition system (MIDAS) [37]. The micro-
ESI flow rate was 0.3 to 0.5 mL/min, and ions were
accumulated in the first octopole for 2–5 s. For dissoci-
ation experiments, stored-waveform inverse Fourier
transform (SWIFT) [38, 39] produced m/z-selective ejec-
tion of ions of all but the desired m/z value, and the
selected ions were then activated by infrared irradiation
with a 40 W CO2 laser (Synrad, Mukilteo, WA)
equipped with a 2.53 beam expander (Synrad) (irradi-
ance power 40–60 W/cm2) leading to multiphoton
fragmentation [40, 41].
Database Search
A specific program was written to search the SWISS-
PROT [11] database subject to criteria from the present
experiments. The first step of the search restricts the
search space by (optional) user-defined specification of
the biological species of the protein. In some examples
shown here, that option was turned off, in order to
search the entire database of possible proteins. The
identity of the N-terminal amino-acid and the mass of
the peptide provide two criteria for a match between
the observed peptide and a segment of a protein in the
database. Two more independent criteria follow from
the proteolytic specificity of trypsin: first, the C-termi-
nal amino acid of the peptide is lysine, arginine, or the
C-terminus of the protein; and second, the N-terminal
amino acid of the peptide is either the N-terminus of the
protein, or is preceded in the protein sequence by lysine
or arginine. The search also includes peptides arising
from incomplete trypsin digestion (i.e., a peptide with
non-terminal arginines and/or lysines). In its current
implementation, the program requires user input of the
N-terminal amino acid and of the mass of the peptide,
but automation of these tasks directly from the MIDAS
analysis package could be added. The SWISS-PROT
database includes 1,512 proteins of horse origin if the
search is restricted to one species, and 85,309 proteins
for the entire database search mode.
Results and Discussion
Bradykinin
The most abundant ion produced by electrospray of
bradykinin is (M 1 2H)21, and Gaskell et al. had pre-
viously shown that gas-phase Edman degradation is
more efficient for doubly-charged peptide ions [33, 36].
PITC (i.e., Edman) derivatization of bradykinin is ;80%
efficient, as evidenced by observed abundance of elec-
trosprayed PTC-bradykinin relative to underivatized
bradykinin (see Figure 1, top). Activation of the ion to
observe its dissociation was performed on SWIFT-
isolated PTC-bradykinin21. IRMPD produces the deri-
vatized b1
1 ion and the complementary y8
1 ion (Figure 1,
bottom). The loss of neutral C6H7N (93 Da) represents
another major fragmentation pathway and can be ratio-
nalized as cleavage of aniline from the PTC moiety after
transfer of a proton. Higher irradiation energy produces
further fragmentation of y8
1, leading to y6
1 (loss of two
prolines), and (y8
1 2 H2O). These results demonstrate
that IRMPD of a PTC-derivatized peptide can produce
efficiently the desired Edman cleavage to reveal the
N-terminal amino-acid of the peptide.
Apomyoglobin
(a) Digestion with trypsin. The derivatization procedure
was carried out on trypsin digests obtained by use of
immobilized and soluble trypsin. Except for the pres-
ence of peaks that can be related to self-digestion of
trypsin, no difference was observed in the results. Thus
all the further results are those obtained with the
immobilized trypsin digest. The efficiency of tryptic
digestion of apomyoglobin was assessed by ESI FT-ICR
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mass analysis of the resulting mixture of peptides. No
underivatized peptide was identified in this spectrum.
Figure 2 shows that 25 peptides were identified, cover-
ing the entire primary amino acid sequence of the
protein. The charge states of these peptides ranged from
singly to triply charged, and more than half were
doubly charged.
(b) PITC derivatization. After derivatization of the (un-
separated) mixture of tryptic peptides with PITC, ESI
FT-ICR MS of the crude reaction mixture showed a
mixture of derivatized peptides. Identification of the
derivatized peptides from each of two different solvent
preparations is summarized in Table 1. Solubility of the
derivatized peptides is more problematic than that of
the underivatized peptides: the choice of the initial
solvent (methanol or acetonitrile) and of the electros-
pray solutions significantly affects the nature and
charge states of the species present in the spectrum.
Because the objective is to generate abundant b1 ions
after fragmentation, a high initial charge state is desir-
able to ensure the availability of a mobile proton to
promote backbone cleavage [1]. Thus, the acetonitrile:
water:formic acid solution (Figure 3) appears better
suited for further MS/MS experiments.
The derivatization procedure is not as simple as
might be hoped: notably, multiple PTC-derivatization
can occur on some peptides. The original target of this
approach was singly PTC-derivatized peptides. How-
ever, PTC-derivatization can occur on any amine group,
including those of the lysine amino acids. Thus, pep-
tides containing no lysines (e.g., V17-R31 or A134-R139)
are singly derivatized, whereas peptides bearing lysines
can be multiply derivatized (e.g., up to 3 added PTC
groups for K79–K96, whose primary sequence contains
Figure 1. (Top) ESI FT-ICR mass spectrum of bradykinin (Bk)
after N-terminal derivatization with phenyl isothiocyanate (PITC).
(Bottom) FT-ICR mass spectrum following IRMPD fragmentation
(5 s laser irradiation) of SWIFT-isolated PTC-derivatized bradyki-
nin.
Figure 2. Tryptic cleavage fragments of myoglobin. Primary sequences (bounded by arrows) of 25
peptides identified in the trypsin digestion of apomyoglobin. Dashed arrows denote isomeric peptides
of exactly the same mass.
Table 1. Phenyl isothiocarbamoyl peptides present in the ESI














(PTC)V17-R31 11 21 21
(PTC)2L32-K42 11 11 21
(PTC)L32-K42 11 11, 21 21
(PTC)2H48-K50 — 11 11
(PTC)2H64-K77 — — 21
(PTC)3K79-K96 21 — —
(PTC)2G80-K96 21 21 21, 31
(PTC)2Y103-K118 21 21 21
(PTC)Y103-K118 21 21 21
(PTC)2H119-K133 — — 21
(PTC)H119-K133 — 21 21
(PTC)A134-R139 — 11 11
aPTC-derivatized peptides dissolved partially in methanol before dilu-
tion.
bDissolved in acetonitrile.
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5 lysines). The possibility of multiple PTC-derivatiza-
tion adds a step to the process: two spectra must be
recorded: one for the mixture of underivatized peptides
and one for the mixture of derivatized peptides. The
presence of multiple PTC groups (counted by searching
for mass differences by integer multiples of 135.0143
(C7H5NS) between these two mass spectra) establishes
the (minimum) number of lysines in that peptide.
Although that additional information was not used in
the present analysis, it could easily be incorporated into
an automated database search.
(c) MS/MS analysis of the derivatized peptides. Five PTC-
derivatized peptides from tryptic cleavage of apomyo-
globin were subjected to MS/MS analysis under the
same conditions as for bradykinin. Figure 4 shows the
result for (PTC)L32-K4221. Fragmentation leading to b1
1
and its complementary y9
1 ion is the dominant path-
way. However, the results for all five peptides (see
Table 2) show that not all ions undergo a clear b1
1
fragmentation. Loss of aniline and/or the entire PTC
derivatizing group can compete with the Edman frag-
mentation pathway. Loss of the entire PTC group
appears to occur only for multiply-derivatized pep-
tides, suggesting that such fragmentation may involve
the group linked to one of the lysine side chains. Aniline
loss is much more general and likely involves the
N-terminal PTC group. No general trend (based on
nature of the N-terminal amino-acid, charge-state of the
peptide, or availability of mobile protons) for aniline
Figure 3. ESI FT-ICR mass spectrum of a mixture of PTC-derivatized trypsin-digestion peptides
from apomyoglobin. The most abundant species are identified and subjected to further IRMPD
MS/MS analysis.
Figure 4. FT-ICR mass spectrum following IRMPD fragmentation (5 s laser irradiation) of the SWIFT
isolated (see inset) (PTC)L32-K4221 derivatized peptide from trypsin-digested myoglobin.
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loss relative to the desired b1 fragmentation, is yet
apparent from this limited set of experimental results.
Fortunately, three derivatized peptides exhibited the
desired Edman-type fragmentation. For the doubly
charged peptides, formation of the singly charged b1
1
ions is accompanied by formation of the complemen-
tary yn21
1 ions. For the singly charged peptide
(PTC)2H48-K50
1, the proton carrying the charge can
remain on either entity of the fragmenting compound,
suggesting that the proton affinities of the correspond-
ing neutrals do not differ greatly. Although the desired
fragmentation to leave a b1
1 N-terminal fragment results
for only three out of five PTC-derivatized tryptic pep-
tides, we shall see that it is nevertheless possible to
identify the original protein (see next section).
To compare this method to the much more accurate
(but also more time-consuming) method of partial se-
quencing by MS/MS, we attempted to photodissociate
three underivatized ions (whose derivatized analogs
undergo specific b1 fragmentation under the same con-
ditions). No significant fragmentation was observed. At
higher laser radiance, only one of the peptides (L32-
K4221) underwent significant fragmentation, allowing
for identification of its five N-terminal amino-acid se-
quence. Although much more information can be ob-
tained by MS/MS (because many fragment ions are
observed vs. only one or two for the derivatized pep-
tide), signal magnitude (and thus sensitivity) is com-
promised after MS/MS.
(d) Database matching. The question at issue is the
extent to which knowledge of the identity of the N-
terminal amino acid of a peptide can narrow the num-
ber of candidate proteins from (in this case) the SWISS-
PROT database [11, 33, 34]. For the most direct
comparison, only the three PTC-derivatized peptides
leading to b1 fragmentation were included in the search;
the mass information from the other peptides was
simply discarded. Table 3 summarizes four search con-
ditions: 50 ppm mass accuracy alone, 10 ppm mass
accuracy alone, and 10 ppm or 50 ppm mass accuracy
combined with knowledge of the N-terminal amino
acid. For apomyoglobin, Table 3 shows that if the
database is restricted to one species, knowledge of the
accurate (to within 10 ppm) mass of three (underivat-
ized) peptides alone suffices for unique identification of
the correct protein. Even so, the additional knowledge
of the N-terminal amino acid (from gas-phase Edman
degradation) identifies the correct protein from any
combination of two of the three peptides, or even from
the single Y103-K118 peptide.
Expanding the search to include the entire SWISS-
PROT database (.85,000 proteins) affords a test of the
protein identification method when the biological spe-
cies is not known in advance. Table 3 shows that even
for the full database, the three peptides used in this
study suffice to identify the protein, provided that high
mass accuracy (10 ppm) is available. Unique identifica-
tion is no longer possible at lower mass accuracy. The
number of candidate proteins based on a single peptide
shows a trend that is expected to be general for any
protein: namely, the number of candidate proteins
decreases monotonically as mass accuracy improves
from 50 ppm to 1 ppm.
Given that there are 20 naturally occurring amino
acids, one might intuitively expect that knowledge of
the N-terminal amino acid would, on average, nar-
row the number of candidate proteins by a factor of
;20 (or by a factor of 10 if the N-terminus is leucine
or isoleucine, which have the same mass). In fact (see
Table 3), at a mass accuracy of 10 ppm for a single
peptide, knowledge of the N-terminal amino acid
reduces the number of candidate proteins by a factor
ranging from (1504/887) ’ 2 to (678/17) ’ 40.
However, not all possible combinations of amino
acids are equally probable in nature. For example, six
out of eleven different proteins that match the 10 ppm
and Edman criteria for two horse apomyoglobin
peptides turn out to be apomyoglobins from other
species (i.e., their sequences are highly conserved). It
is heartening to note that inclusion of a third peptide
resolves even this highly non-statistical barrier to
produce a unique identification.
Adding partial sequence information for one of the
peptides of course yields much more accurate identifi-
cation [42, 43]. For example, for the (I/L)-1270 peptide,
for which partial sequence is available (five N-terminal
amino-acids), knowledge of the first amino-acid re-
duces the number of possible matches from 506 to 65.
Extending the sequence further reduces the number of
possible matches to only 7. In fact, close examination
reveals that only the second N-terminal amino-acid is
Table 2. Abundances (relative to the most abundant ion in the product ion spectrum including the precursor) of infrared
multiphoton dissociation (IRMPD) fragments of the six most abundant ions in the (CH3CN:H2O:HCOOH, 50:50:2) ESI FT-ICR mass
spectrum of the mixture of PTC-derivatized tryptic digest peptides from apomyoglobin. SWIFT [39, 40] isolation of ions of each m/z





(PTC)V17-R3121 — — — 46.5 —
(PTC)L32-K4221 24.7 39.1 18.0 8.0 —
(PTC)2H48-K50
11 5.6 31.7 — — 5.8
(PTC)2Y103-K118
21 — — — 29.8 100.0
(PTC)Y103-K11821 8.9 — — 47.8 —
(PTC)A134-R13911 — — — 100.0 —
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required for such a match—no additional improvement
is provided by knowledge of the remaining amino
acids.
Conclusion
From the present preliminary results, it is clear that
identification of the N-terminal amino-acid can narrow
the search space for peptides by an order of magnitude,
allowing for unique identification of a candidate pro-
tein from just a few peptides. Even without any exper-
imental optimization, the search process could be opti-
mized in several ways. First, knowledge of the accurate
masses of all (rather than just a few) underivatized
tryptic peptides could be included. Second, 10 ppm
mass accuracy (routine for broadband ESI FT-ICR mass
analysis of peptide mixtures) can be reduced to ;1 ppm
by internal mass calibration. For unmodified amino
acids, not much improvement can be expected beyond
;5 mDa mass accuracy, because relatively few peptides
differ by less than that value (except for isomers). Third,
multiple PTC-derivatization defines the minimum
number of lysines in a peptide, and that information
could be added to the search criteria. Fourth, two-
dimensional FT/FT ICR MS techniques [44, 45] hold the
promise of multiplexing the experiment, so that many
(rather than just one) parent peptide ion could be
dissociated at a time.
Various aspects of the dissociation of gas-phase
PTC-derivatized peptides remain to be explored. Why
does the specific b1 fragmentation not occur for all
PTC-derivatized peptides, and what determines
whether M-93 fragmentation will dominate? Based on
loss of aniline, one thinks immediately of intermedi-
ate protonation on the nitrogen connected to the
phenyl group, depending in turn on the respective
basicities of neighboring protonation sites, which are
themselves presumably determined by side chain
identity and peptide ion conformation. If a general
pattern can be found and explained, the absence of b1
fragmentation (information currently discarded)
might contribute additional search constraints on the
N-terminal composition of the peptide. Finally, it will
be necessary to scale down the PITC derivatization
reaction to make the overall process competitive with
existing mass-based protein identification methods.
The electrospray FT-ICR mass analysis is already
sensitive enough—in the present experiments, only
1/1000 of the final sample amount was actually used for
ESI FT-ICR MS.
More generally, because so few peptides are needed
to identify a protein uniquely by the present method,
inclusion of more peptides for a given protein could
exploit the redundancy of the available information,
leading to identification of proteins even if some of their
peptides have been chemically modified and thus may
not appear in the database. Knowledge of each pep-
tide’s N-terminal amino-acid from accurate mass and
gas-phase Edman degradation could further reduce the
number of candidates, and facilitate identification of the
corresponding unmodified peptide, and of its modifi-
cation.
In conclusion, the combination of accurate mass
measurement (to 10 ppm) and gas-phase Edman deg-
radation of tryptic peptides already appears to offer a
robust means for unique identification of a protein from
database candidates, without the use of HPLC separa-
tion of peptides at any stage of the analysis. Further
optimization of the experiment (notably improvements
in PITC derivatization efficiency and gas-phase Edman
cleavage efficiency to yield the N-terminal amino acid
identity) and the search algorithm (notably inclusion of
underivatized peptide masses and number of lysines
per peptide) could make this approach highly attractive
for protein identification.
Table 3. Number of SWISS-PROT database matches for candidate proteins, based on masses of three tryptic peptides whose PTC-
derivatives yielded b1
1 ions upon MS/MS. Search constraints were: (a) 50 ppm mass accuracy for underivatized tryptic peptides, (b)
10 ppm mass accuracy for underivatized tryptic peptides, (c) constraint (a) or (b) plus knowledge of the N-terminal amino acid based
on gas-phase Edman degradation and (d) constraint (b) plus knowledge of the partial sequence of the L32-K42 peptide
Horse Full database
Edman






& 50 ppm 10 ppm 50 ppm
One peptide
H-396a 9 15 887 — 887 1504 1504
(I/L)-1270 3 8 65 7 267 506 2418
Y-1884 1 20 17 — 48 678 2733
Two peptides
H-396 and (I/L)-1270 1 1 9 7 13 16 67
H-396 and Y-1884 1 2 3 — 6 21 73
(I/L)-1270 and Y-1884 1 1 1 1 1 5 117
Three peptides 1 1 1 1 1 1 9
aValues used for the search: the letter is the N-terminal amino-acid, as identified by the Edman fragmentation, the number is the rounded mass.
H-396 denotes H48-K50, M 5 396.2485; (I/L)-1270 denotes L32-K42, M 5 1270.656; and Y-1884 denotes Y103-K118, M 5 1884.015.
bAs noted in the text: photofragmentation of (I/L)-1270, leading to the partial N-terminal sequence (I/L)FTGH.
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